Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Vitamin B6 on the Exercise Pressor Reflex in Lower Limb Ischemia-Reperfusion
NCT06369350Phase 1Not yet recruiting
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Dec 2027
- Primary completion
- Sep 2028
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of pyridoxine in peripheral artery disease (PAD) and ischemia-reperfusion injury (IRI) (4 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Blood pressure up to 31 days, Heart Rate up to 31 days and 2 more. Planned start Dec 2027; status: not yet recruiting.
02
Drugs
pyridoxine
03
Conditions
peripheral artery disease (PAD)ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT06369350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06369350.